Frankfurt - Delayed Quote EUR

Cryoport, Inc. (CKX.F)

4.7600

+0.0600

+(1.28%)

At close: April 17 at 9:17:15 AM GMT+2

C.H. Robinson (CHRW) Surges 5.7%: Is This an Indication of Further Gains?

C.H. Robinson (CHRW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 10 days ago

CHRW

CYRX
UBS Says It’s Time to Go Bargain Hunting; Here Are 2 Stocks Poised for a Rebound

The major indexes are in freefall ahead of the open on Thursday, as the markets appear to be digesting the impact of what Donald Trump has declared “Liberation Day” for the US. After imposing a 10 percent tax on all imported goods along with additional “reciprocal” tariffs on certain major trading partners amid an intensifying trade war, concerns are growing over its potential economic repercussions. However, according to the investment office at UBS, it’s not all necessarily doom and gloom. The

TipRanks 17 days ago

PRM

CYRX
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"

DHL Group ("DHL"), the world's leading logistics provider, and Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global provider of supply chain solutions for the life sciences sector, are pleased to announce that DHL has acquired 100% of CRYOPDP, a leading specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context, the companies also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and health

PR Newswire 20 days ago

CYRX
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences sector, today announced that the Company will host an investor call today, Monday, March 31, 2025, at 8:30 a.m. ET, to discuss the Company's recent strategic agreement and transformative transaction, which includes a strategic partnership with the DHL Group (DHL) and DHL's acquisition of CRYOPDP

PR Newswire 20 days ago

CYRX
Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?

We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a look at where Cryoport, Inc. (NASDAQ:CYRX) stands against the pump and dump stocks. Pump and dump stocks are typically characterized by high 52-week volatility, often experiencing rapid price surges followed […]

Insider Monkey last month

CYRX
CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?

CryoPort (CYRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks last month

CYRX
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High-Efficiency 800 C, the latest addition to its next-generation High-Efficiency ("HE") Series of cryogenic freezers. The HE 800 C combines ergonomic features and consistent performance in a compact size to meet the evolving needs of fertility clinics, biorepositories and clinical laboratories.

PR Newswire last month

CYRX
Cryoport Full Year 2024 Earnings: EPS Misses Expectations

Cryoport ( NASDAQ:CYRX ) Full Year 2024 Results Key Financial Results Revenue: US$228.4m (down 2.1% from FY 2023). Net...

Simply Wall St. last month

CYRX
CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

CryoPort Inc (CYRX) reports robust growth in cell and gene therapy revenues and improved gross margins, despite facing macroeconomic headwinds.

GuruFocus.com last month

CYRX
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates

CryoPort (CYRX) delivered earnings and revenue surprises of -27.27% and 0.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

CYRX

REVG
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results

Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences industry, today announced financial results for the fourth quarter (Q4) and year ended (FY) December 31, 2024.

PR Newswire last month

CYRX
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2024 on Tuesday, March 4, 2025 after U.S. markets close.

PR Newswire last month

CYRX
Cryoport (NASDAQ:CYRX) investors are sitting on a loss of 80% if they invested three years ago

While it may not be enough for some shareholders, we think it is good to see the Cryoport, Inc. ( NASDAQ:CYRX ) share...

Simply Wall St. 2 months ago

CYRX
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today unveiled its Cryoport Express® Cryogenic HV3 Shipping System ("HV3"), the Company's newest product innovation in Cryoport's comprehensive portfolio of global end-to-end temperature-controlled supply chain offerings.

PR Newswire 2 months ago

CYRX
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer center, through its wholly owned subsidiary Speros FL, a 775-acre global innovation life sciences campus, and Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences industry, today announced a strategic collaboration that will provide CRYOGENE's state-of-the-art biorepository services to Speros in Pasco County, Florida. Cryoport's CRYOGENE business unit is a leading

PR Newswire 3 months ago

CYRX
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences industry, today announced that MVE Biological Solutions ("MVE"), a Cryoport company and the leading global manufacturer of high-quality cryogenic freezers and dewars, has officially registered all three of its manufacturing facilities (located in Ball Ground, Georgia; New Prague, Minnesota; and Chengdu, China) with the U.S. Food and Drug Administration ("FDA"). Additionally, all applicable MVE-manufact

PR Newswire 3 months ago

CYRX
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced the opening of its newest IntegriCell™ facility in Villers-le-Bouillet, Liege, Belgium. The Center of Excellence is now fully operational and prepared to support the development and commercialization of cell-based therapies with advanced cryopreservation solutions for leukapheresis, a common starting material.

PR Newswire 5 months ago

CYRX
Cryoport Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cryoport ( NASDAQ:CYRX ) Third Quarter 2024 Results Key Financial Results Revenue: US$56.7m (flat on 3Q 2023). Net...

Simply Wall St. 5 months ago

CYRX
CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges

CryoPort Inc (CYRX) reports robust growth in life sciences services and maintains full-year revenue guidance despite sector-specific hurdles.

GuruFocus.com 5 months ago

CYRX
CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

CryoPort (CYRX) delivered earnings and revenue surprises of 92% and 2.52%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 months ago

CYRX

Performance Overview

Return	CKX.F	S&P 500 (^GSPC)
YTD	-34.34%	-10.18%
1-Year	-69.87%	+5.19%
3-Year	-81.30%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cryoport, Inc. (CKX.F)

C.H. Robinson (CHRW) Surges 5.7%: Is This an Indication of Further Gains?

UBS Says It’s Time to Go Bargain Hunting; Here Are 2 Stocks Poised for a Rebound

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"

Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET

Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds?

CryoPort (CYRX) Surges 5.9%: Is This an Indication of Further Gains?

Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories

Cryoport Full Year 2024 Earnings: EPS Misses Expectations

CryoPort Inc (CYRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates

Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results

Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Cryoport (NASDAQ:CYRX) investors are sitting on a loss of 80% if they invested three years ago

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Cryoport Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

CryoPort Inc (CYRX) Q3 2024 Earnings Call Highlights: Strong Service Growth Amid Market Challenges

CryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue Estimates

Performance Overview